If you have the article's Nostr address (naddr), paste it in the search box below. We'll attempt to fetch it from the relays and add it to our index.
Looking for people? Search users
An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a late-stage trial, according to data released Sunday.
Dr. Keith Humphreys is a professor of psychiatry and behavioral sciences at Stanford School of Medicine and a leading expert on treating addictions, drug laws and policy. We discuss all the major
Louisiana Attorney General Liz Murrill (R) blasted California officials this week for refusing to extradite a doctor facing abortion charges.Murrill said that it was "appalling" to see Gov. Gavin Newsom (D) and California Attorney General Rob Bonta (D) "openly admitting that they will protect an individual from being held accountable for illegal, medically unethical, and dangerous conduct that led to a woman being coerced into terminating the life of her unborn child."Remy Coeytaux was charged on Jan. 8 in St. Tammany Parish with criminal abortion by means of abortion-inducing drugs, a crime that carries a maximum sentence of 50 years of hard labor.'The trauma of my chemical abortion still haunts me.'Murrill announced on Tuesday — several months after indicating that she would "pursue anyone and use any legal means available" to hold accountable those who distribute abortion pills in the Bayou State — that a criminal arrest warrant had been signed for Coeytaux and his name had been entered into the National Crime Information Center.Roughly an hour later, Republican Gov. Jeff Landry indicated that he was "signing the extradition paperwork to bring this California doctor to justice.""Louisiana has a zero tolerance policy for those who subvert our laws, seek to hurt women, and promote abortion," said Landry. "I know Gavin Newsom supports abortion in all its forms, but that doesn't work in Louisiana. We are unapologetically pro-life."RELATED: Pro-abortion doctor gets dismantled by Hawley on men and pregnancy: 'I don't know how we can take you seriously' Shuran Huang for the Washington Post via Getty Images Newsom said in response that "Louisiana's request is denied.""We will not allow extremist politicians from other states to reach into California and try to punish doctors based on allegations that they provided reproductive health care services. Not today. Not ever," said Newsom. "We will never be complicit with Trump’s war on women."Newsom suggested that this frustration of Louisiana justice was consistent with his 2022 executive order directing California to decline extradition requests for doctors accused of providing or facilitating abortions.Nancy Northup, the president and chief executive of the Center for Reproductive Rights, which is representing Coeytaux in a separate civil case, told the New York Times that the allegations "are unproven and should not be reported as fact.""Women should also be able to get safe and legal abortion care in their own state," added Northup. "Thousands of women seek abortion pills via mail every year because abortion is banned in their state, and that will not change until abortion is legal everywhere."While characterized as safe, abortion pills not only kill unborn children but endanger women's lives. The Ethics and Public Policy Center noted in a report last year that over 10% of women "experience sepsis, infection, hemorrhaging, or another serious adverse event within 45 days following a mifepristone abortion."Coeytaux is accused in a federal lawsuit of sending abortion pills to a Louisiana woman in 2023 — a woman who has indicated she was pressured to take the drugs and is now "haunt[ed]" by her chemical abortion.Rosalie Markezich, the recipient of the drug and now suffering from the fallout of the abortion, claimed in a September court filing that despite initially celebrating her pregnancy, her boyfriend "soon changed his mind," then used her personal email address and mailing address to obtain mifepristone and misoprostol "from an online provider that his sister has used multiple times before."A few days after allegedly forwarding to Coeytaux the $150 her boyfriend sent her, Markezich received the drugs by mail.According to her declaration, Markezich changed her mind about killing her child, but her boyfriend, who "had anger issues and a criminal record," allegedly coerced her into taking them — and she proved unable to throw them back up."The trauma of my chemical abortion still haunts me," said Markezich.Coeytaux is also named in a civil complaint filed in July with the federal court for the Southern District of Texas. The Texas complaint alleges that a woman, Kendal Garza, was pressured by her estranged husband to use abortion drugs allegedly obtained from Coeytaux "to murder" Garza's unborn child by another man.Texas Attorney General Ken Paxton (R) ordered Coeytaux on Aug. 14 to cease and desist from mailing abortion drugs into the state of Texas and indicated such conduct not only violates Texas state law but the federal Comstock Act of 1873, which prohibits the mailing of abortion-related drugs.Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!
My guest is Dr. David Fajgenbaum, MD, professor of translational medicine and human genetics at the University of Pennsylvania. He explains how, unbeknownst to most doctors, many approved medications
Jasmin Sangha, known as the 'Ketamine Queen,' has been sentenced to 15 years in prison for her role in supplying the fatal dose of ketamine that caused the death of actor Matthew Perry. Sangha admitted to distributing ketamine resulting in death as part of a plea agreement.
The Food and Drug Administration awarded priority review vouchers to three companies developing psychedelic-based treatments for mental health conditions -- two studying psilocybin for hard-to-treat depression and one studying methylone, an MDMA-related drug, for PTSD.
Pharmaceutical company Eli Lilly announced plans to invest over $3.5 billion to build a new manufacturing plant in Pennsylvania's Lehigh Valley. The facility will produce the company's next-generation injectable obesity drugs and is expected to create 850 jobs.
Planned Parenthood has begun prescribing abortion pills to women before they get pregnant, defying the Food and Drug Administration's safety protocol and heightening concerns about the drugs being used by bad actors to induce non-consensual abortions.
"Everything came suddenly. You are never ready for that sentence. The moment you hear the diagnosis is like someone turned off the sound in the world for you – everything stops. And yes, in that first moment you think it's the end. That's human. The hardest thoughts go through your head – what will happen to my family, will I survive, why me?", says Ana Dornik to Danas, one of the women who beat breast cancer, and today her mission is to empower other women going through this battle for life.
Imagine your doctor diagnoses you with Alzheimer’s disease, evaluates your needs and risks, and recommends a tailored treatment plan to extend your healthy years. Who should have the final say over whether you pursue that care: you, your family, and your doctor — or an insurance company that has never met you?For most Americans, the answer is obvious. Doctors and patients should make care decisions.If policymakers want fewer insurance denials, they should stop creating incentives for them.Yet in many cases, insurers end up with the final say.New polling from Market Institute and President Trump’s pollster Fabrizio Ward found that 89% of registered voters believe doctors often choose not to prescribe Alzheimer’s tests or treatments because they know insurers are unlikely to cover them and patients cannot afford to pay out of pocket.Voters are recognizing a real trend. Alzheimer’s patients have made headlines for benefiting from new treatments, only to receive abrupt coverage denials from their insurance companies.Treatment allowed one patient, Lori Baetz, to return to her daily routine. When coverage was pulled back, she deteriorated, even getting lost in her own neighborhood. Lori’s neurologist, Dr. Cara Leahy, wrote that her patients are repeatedly denied coverage. Similar denials are happening across the country, including in New Jersey and North Carolina, and across insurers.Thousands of Americans find these delays and denials unjust. In fact, a shocking 41% of young Americans said the murder of UnitedHealthcare CEO Brian Thompson was “acceptable.” One voter from a Market Institute focus group said of insurance companies, “They just want to wear you down ... so you just give up.”Americans’ frustration is understandable. But insurance companies are often following rules set by the federal government.The real culprits are the behind-the-scenes government policies that encourage insurers to delay and deny coverage.The clearest example is a Biden-era Medicare policy known as Coverage with Evidence Development.After the Food and Drug Administration approved a new generation of Alzheimer’s therapies, the Centers for Medicare and Medicaid Services took the unprecedented step of limiting Medicare coverage unless patients participated in government-approved studies and met additional requirements.RELATED: Trump DOJ charges 455 people allegedly tied to $6.5B in health care fraud Feodora Chiosea/iStock/Getty ImagesThat created a second layer of red tape after the FDA had already deemed the therapies safe and effective.The decision sent a powerful signal throughout the health care system. When Medicare, the nation’s largest health care payer, treats FDA approval as insufficient, private insurers follow.When Lori’s coverage was denied despite her positive response to treatment, the company described the therapy as “investigational/experimental,” even though the FDA had approved it. The company was following Medicare’s lead. When Medicare treats approved therapies as experimental by requiring additional paperwork and registration, insurers can cite the government’s own policy when denying coverage.That bad policy worsens the financial and human cost of Alzheimer’s disease.The lifetime cost of caring for a person with Alzheimer’s exceeds $400,000, with families shouldering roughly 70% of that burden through unpaid caregiving and out-of-pocket expenses.Meanwhile, Medicare spends roughly $174 billion annually on Alzheimer’s patients, while Medicaid spends another $72 billion, much of it on long-term care. As Alzheimer’s cases double over the next few decades, those costs will continue to climb.The good news is that treatment could help curb those mounting costs by keeping Americans independent and in the workforce longer.According to USC Schaeffer research, providing treatment before symptoms fully emerge could add a full year of life, reduce nursing home stays by nearly two years, and lower medical spending by roughly $48,000 per patient. That means more Americans remaining independent, fewer families crushed by caregiving burdens, and more workers preserving their economic productivity.Every patient who remains independent, stays out of a nursing home, or delays the need for full-time care represents both a human victory and an economic one.If policymakers want fewer insurance denials, they should stop creating incentives for them.The FDA is charged with determining whether a therapy is safe and effective. Once it does, CMS should not erect a second regulatory barrier that encourages insurers to do the same.Until that changes, Americans will continue blaming insurance companies for behavior government policy encourages.
President Trump signed an executive order Saturday to fast-track access to medical psychedelic drug research and treatment.
